Risk of drug-related problems for various antibiotics in hospital: assessment by use of a novel method
Related Experiment Video
Updated: Jul 6, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Hege Salvesen Blix1, Kirsten K Viktil, Tron Anders Moger
1Lovisenberg Diakonale Hospital, Oslo, Norway. hege.salvesen.blix@fhi.no
Purpose:
To investigate the use of antibiotics in hospitals, to explore drug-related problems (DRPs) linked to antibiotics and to introduce a novel way of expressing the risks accompanying use of various antibiotics.
Methods:
Patients from internal medicine departments in four Norwegian hospitals were prospectively included in 2002. Demographics, drugs used, medical history, laboratory data and clinical/pharmacological risk factors were recorded. DRPs were identified by clinical pharmacists and assessed in multidisciplinary hospital teams. A new term, the drug risk ratio, was established and defined as the number of times the antibiotic was associated with DRPs in relation to the number of times it was used.
Results:
Out of the 668 patients included, 283 patients (42%) used antibiotics (AB users). AB users were older (76.2 vs. 73.9), used more drugs on admission (5.1 vs. 4.4) and had more DRPs (3.0 vs. 2.2) than non-users. The DRP categories no further need for drug, non-optimal drug and non-optimal dose were most frequently observed. The drug risk ratio, calculated for 12 antibiotic groups, was highest for aminoglycosides (0.77), beta-lactamase-resistant penicillins (0.56), macrolides (0.54) and quinolones (0.48) and lowest for first- and third-generation cephalosporins, 0.17 and 0.13, respectively.
Conclusions:
Nearly half of the hospitalised patients were prescribed antibiotics and antibiotic associated DRPs occurred frequently. The drug risk ratio for the different antibiotic groups varied with a factor of six from the lowest to the highest. A high drug risk ratio would alert of antibiotics which require heightened awareness when going to be used in clinical practice.
Insights
Antibiotic-associated drug-related problems (DRPs) are common in hospitalized patients. A new drug risk ratio highlights significant variations in antibiotic risks, aiding clinical practice awareness.
Area of Science:
- Clinical Pharmacy
- Infectious Diseases
- Pharmacovigilance
Background:
- Antibiotic use is prevalent in hospital settings.
- Drug-related problems (DRPs) are a significant concern in patient care.
- Quantifying antibiotic-specific risks is crucial for safe prescribing.
Purpose of the Study:
- To investigate antibiotic utilization in hospitals.
- To identify and analyze drug-related problems (DRPs) associated with antibiotic use.
- To introduce a novel metric, the drug risk ratio, for assessing antibiotic-related risks.
Main Methods:
- Prospective study of internal medicine patients across four Norwegian hospitals in 2002.
- Collection of patient demographics, medication data, medical history, and laboratory results.
- Identification and assessment of DRPs by clinical pharmacists and multidisciplinary teams.
- Definition and calculation of the drug risk ratio: DRPs per antibiotic use.
Main Results:
- 42% of 668 patients used antibiotics; these patients were older and had more DRPs.
- Most frequent DRP categories included 'no further need for drug', 'non-optimal drug', and 'non-optimal dose'.
- Drug risk ratios varied significantly across antibiotic classes, with aminoglycosides (0.77) and beta-lactamase-resistant penicillins (0.56) being highest, and cephalosporins (0.17-0.13) lowest.
Conclusions:
- Antibiotic-associated DRPs are frequent in hospitalized patients.
- The drug risk ratio demonstrates a six-fold variation in risk among antibiotic groups.
- A high drug risk ratio signals antibiotics requiring heightened clinical vigilance.
Related Concept Videos
Automated Microbial Diagnostics
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Urine Studies II: Urine Culture and Sensitivity Test
Clinical Significance of Antibiotic Resistance
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Mechanism of Antibiotic Resistance in MRSA
